What Is This?
This blend pairs CJC-1295 (a growth-hormone-releasing hormone analog) with Ipamorelin (a selective ghrelin receptor agonist). Together they form the standard research combination for studying how the pituitary gland releases growth hormone in pulses - like the body does naturally.
What's In the Vial
- CJC-1295 (without DAC) - 5 mg
- Ipamorelin - 5 mg
What Do Researchers Study?
CJC-1295 stimulates the GHRH receptor with a short half-life suited for pulse-pattern research in pituitary cell cultures. Ipamorelin adds ghrelin receptor activation with minimal impact on cortisol and prolactin pathways - a selectivity that distinguishes it from older GHRP compounds. Together they are the standard in vitro combo for studying growth hormone axis signaling.
Common Research Uses
- Pulsatile growth hormone release studies in pituitary cultures
- IGF-1 axis research in liver hepatocyte and pituitary cell models
- Selectivity tests vs older GH-releasing peptides
- Downstream fat and muscle metabolism marker studies in cultured cells
- GHRH and ghrelin receptor binding and dose-response assays
What the Science Is Looking At
- Two peptides work together to trigger natural-style growth hormone pulses in pituitary cell models
- Ipamorelin is selective - mainly hits GH release without spiking cortisol or prolactin markers
- Standard reference combo for studying the growth and repair signaling axis in vitro
- Used to observe downstream effects on IGF-1, fat metabolism, and muscle cell markers
- Pre-mixed 5 mg + 5 mg ratio eliminates manual blending errors at the bench
How It Works - In Plain English
GHRH Stimulation
CJC-1295 (no DAC) activates GHRH receptors with a short half-life - suited for studying pulse-pattern hormone release rather than flat, continuous elevation.
Selective GHRP
Ipamorelin stimulates the ghrelin receptor with minimal cortisol or prolactin side effects compared to older GHRP compounds like GHRP-6.
Synergy
Combined use produces stronger GH release in pituitary cell models than either peptide alone - a synergy researchers quantify with GH ELISA readouts.
Downstream IGF-1
Growth hormone released in culture triggers IGF-1 production in liver cell models - letting labs trace the full axis from pituitary to hepatocyte in one workflow.
Product Specifications
| Total content | 10 mg per vial (5 mg each) |
|---|---|
| Form | Lyophilized powder |
| Purity | 99%+ (HPLC) |
| Storage | -20 C |
Order CJC / Ipamorelin
99%+ Purity • Third-Party Tested • COA Included • Ships Canada 1-2 Days
Multi-vial deal: 2+ vials of this peptide = $10 off per vial!